US FDA accepts MS drug Lemtrada resubmission for review
US FDA accepts MS drug Lemtrada resubmission for review
The US Food and Drug Administration (FDA) has accepted for review the Genzyme's resubmission of supplemental Biologics License Application (sBLA) seeking approval of Lemtrada (alemtuzumab) for the treatment of relapsing forms of multiple sclerosis. A six-month review period has been assigned for the Lemtrada sBLA. Genzyme expects FDA action on the sBLA in the fourth quarter...... Read More - http://www.ms-uk.org/lemtrada
MS-UK - http://www.ms-uk.org/
-
- Similar Topics
- Replies
- Views
- Last post
-
- 0 Replies
- 1980 Views
-
Last post by frodo
-
- 0 Replies
- 1735 Views
-
Last post by frodo
-
- 0 Replies
- 1444 Views
-
Last post by NHE
-
- 1 Replies
- 1846 Views
-
Last post by frodo
-
- 0 Replies
- 2221 Views
-
Last post by NHE
-
- 0 Replies
- 1288 Views
-
Last post by frodo
-
- 0 Replies
- 2611 Views
-
Last post by NHE
-
- 1 Replies
- 1556 Views
-
Last post by NHE
-
- 0 Replies
- 1875 Views
-
Last post by frodo